Gastric cancer;Cancer de l'estomac

Cancer/Radiotherapie

Volumn 14, Issue SUPPL. 1, 2010, Pages

  Mineur, L ^a   Jaegle, E ^a   Pointreau, Y ^b   Denis, F ^c  

^a INSTITUT SAINTE CATHERINE   (France)

^b CHU BRETONNEAU   (France)

^c CENTRE JEAN BERNARD   (France)

Author keywords

Atl; Conformal radiotherapy; Gastric cancer; Target volumes

Indexed keywords

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; HUMAN; OVERALL SURVIVAL; PERIOPERATIVE PERIOD; PHYSICIAN; POSTOPERATIVE CARE; PRIORITY JOURNAL; STOMACH CANCER; TREATMENT PLANNING;

COMBINED MODALITY THERAPY; GASTROINTESTINAL NEOPLASMS; HUMANS; RADIOTHERAPY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, ADJUVANT; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 78649781278     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1278-3218(10)70011-1     Document Type: Article

References (36)

1. Abraham T. Adjuvant Chemotherapy for gastric. Cancer.N engl J Med 2002, 346:210.
2. Agence nationale pour le développement de l'évaluation médicale. Nutrition artificielle périopératoire en chirurgie programmée de l'adulte. Conférence de consensus - 16 décembre 1994). Texte long. 159, rue Nationale 75640 Paris, Cedex 13.
3. Arsene D., Chomontowski J., Pottier D., Rougereau A., Launoy G., Gignoux M. Epidémiologie et pronostic des carcinomes gastriques dans le département du calvados. Gastroenterol Clin Biol 1995, 19:797-803.
4. Atkins C. Adjuvant Chemoradiotherapy for gastric Cancer. N Engl J Med 2002, 346:210.
5. Baeza M.R., Giannini T.O., Rivera S.R., González P., González J., Vergara E., et al. Adjuvant radiochemotherapy in the treatment of completely resected, locally advanced gastric cancer. Int J Radiat Oncol Biol Phys 2001, 50:645-650.
6. Bonenkamp J.J., Songun I., Hermans J., Sasako M., Welvaart K., Plukker J.T., et al. Randomized comparison of morbidity after D1 and D2 resection for gastric cancer in 996 dutch patients. Lancet 1995, 345:745-748.
7. Cancer statistics 2002. Annual age-adjusted Cancer Death Rates by Gender United States, 1973 to 1998. CA A Cancer Journal for Clinicians 2002;52:42.
8. Cunningham D., Allum W.H., Stenning S.P., Thompson J.N., Van de Velde C.J., Nicolson M., et al. MAGIC Trial Participants. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006 Jul 6, 355:11-20.
9. Compton CC, Edge SB, Byrd DR, Fritz AG. Greene FL, Trotti A. AJCC Cancer Staging Manuel TNM UICC Classification of Malignant Tumours - 7th edition Springer.
10. Caudry M., Ratoanina J.L., Escarmant P., Maire J.P. Target volume in radiotherapy of gastric adenocarcinoma. Cancer Radiother 2001, 5:523-533.
11. Cooper C., Jeffrey B., Silverman P.M. Federle MP Comput Assist Tomogr 1986, 10:62-66.
12. Dahan L., Atlan D., Bouché O., Mitry E., Ries P., Artru P., et al. Postoperative chemoradiotherapy after surgical resection of gastric adenocarcinoma: can LV5FU2 reduce the toxic effects of the MacDonald regimen? A report on 23 patients. Gastroenterol Clin Biol 2005, 29:11-15.
13. Dewitt L., Anninga J.K., Hoefnagel C.A., Nooijen W.J. Radiation injury in the human kidney: a prospective analysis using specific scintigraphic and biochemical endpoints. Int J Radiat Oncol Biol Phys 1990, 19:977-983.
14. Faivre J., Forman D., Esteve J., Gatta G. Survival of patients with oesophageal and gastric cancers in Europe. EUROCARE Working Group. Eur J Cancer 1998, 34:2167-2175.
15. A comparison of combination chemotherapy and combined modality therapy for locally advanced gastric carcinoma. Cancer 1982, 49:1771-1777. Gastrointestinal Tumor Study group.
16. Gunderson L.L., Hoskins B., Cohen A., Kaufman S., Wood W., Carey R. Combined modality treatment of gastric cancer. Int J Radiation Oncology Biol Phys 1983, 9:965-975.
17. Gunderson L.L., Sosin H. Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 1982, 8:1-11.
18. Henning G.T., Schild S.E., Stafford S.L., Donohue J.H., Burch P.A., Haddock M.G., et al. Results of irradiation or chemoirradiation following resection of gastric adenocarcinoma. Int J Radiat Oncol Biol Phys 2000, 46:589-598.
19. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma 2nd English Ed. Gastric Cancer 1998; 1:10-24.
20. Kunisaki C., Shimada H., Yamaoka H., Takahashi M., Ookubo K., et al. Indications for paraaortic lymph node dissection in gastric cancer patients with paraaortic lymph node involvement. Hepatogastroenterology 2000, 47:586-589.
21. Landry J., Tepper J.E., Wood W.C., Moulton E.O., Koerner F., Sullinger J. Patterns of failure following curative resection of gastric carcinoma. Int J Radiat Oncol Biol Phys 1990, 19:1357-1362.
22. Larkin M. Thwarting the dwindling progression of cachexia. Lancet 1998, 351:1336.
23. Le Page M., Cauvin J.M., Le Dreau G., Nousbaum J.B., Enard L., Gourlaouen A., et al. Prise en charge thérapeutique et survie de l'adénocarcinome gastrique dans le département du Finistère entre 1984 et 1989. Gastroenterol Clin Biol 1995, 19:804-810.
24. Macdonald J.S., Smalley S.R., Benedetti J., Hundahl S.A., Estes N.C., Stemmermann G.N., et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastrooesophageal junction. N Engl J Med 2001, 345:725-730.
25. Maruyama K., Gunven P., Okabayashi K. Lymph node metastases of gastric cancer: general pattern in 1931 patients. Ann Surg 1989, 210:596-602.
26. Matzinger O., Gerber E., Bernstein Z., Maingon P., Haustermans K., Bosset J.F., et al. EORTC-RTOG expert opinion: radiotherapy volume and treatment guidelines for neoadjuvant radiation of adenocarcinomas of the gastroesophageal junction and the stomach. Radiother Oncol 2009, 92:164-175.
27. Ménégoz F, Chérié-Challine L. Le cancer en France: incidence et mortalité. Situation en 1995, évolution entre 1975 et 1995. Ministère de l'emploi et de la solidarité, Réseau FRANCIM. La documentation Française 1997:40-3.
28. Mehta V.K., Poen J.C., Ford J.M., Oberhelman H.A., Vierra M.A., Bastidas A.J., et al. Protracted venous infusion 5-fluorouracil with concomitant radiotherapy compared with bolus 5-fluorouracil for unresectable pancreatic cancer. Am J Clin Oncol 2001, 24:155-159.
29. Mehta V.K., Fisher G.A., Ford J.M., Oberhelman H.A., Vierra M.A., Bastidas A.J., et al. Adjuvant radiotherapy and concomitant 5-fluorouracil by protracted venous infusion for resected pancreatic cancer. Int J Radiat Oncol Biol Phys 2000, 48:1483-1487.
30. Mineur L., Chastel D., Garcia R., Molinari N., Reboul F. Standardisation d'une ballistique à quatre faisceaux ou cinq faisceaux dans le traitement des cancers gastriques par irradiation en situation pré ou postopératoire. Cancer radiothérapie 2006, 10:501.
31. Msika S., Tazi M.A., Benhamiche A.M., Couillault C., Harb M., Faivre J. Population-based study of diagnosis, treatment and prognosis of gastric cancer. Br J Surg 1997, 84:1474-1478.
32. Poen J.C., Collins H.L., Niederhuber J.E., Oberhelman H.A., Vierra M.A., Bastidas A.J., et al. Chemo-radiotherapy for localized pancreatic cancer: increased dose intensity and reduced acute toxicity with concomitant radiotherapy and protracted venous infusion 5-fluorouracil. Int J Radiat Oncol Biol Phys 1998, 40:93-99.
33. Smalley S.R., Gunderson L., Tepper J., Martenson J.A., Minsky B., Willett C., et al. Gastric surgical adjuvant radiotherapy consensus report: rationale and treatment implementation. Int J Radiat Oncol Biol Phys 2002, 52:283-293.
34. SNFGE. Thésaurus national de cancérologie digestive © http://www.snfge.asso.fr/.
35. Willett C., Tepper J., Orlow E.L., Shipley W. Renal complications secondary to radiation treatment of upper abdominal malignancies. Int J Radiat Oncol Biol Phys 1986, 12:1601-1604.
36. Wysocka B., Kassam Z., Lockwood G., Brierley J., Dawson L.A., Buckley C.A., et al. Interfraction and respiratory organ motion during conformal radiotherapy in gastric cancer. Int J Radiat Oncol Biol Phys 2010, 77:53-59.